{"id":"https://openalex.org/W2160001758","doi":"https://doi.org/10.2337/dc08-2124","title":"Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)","display_name":"Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)","publication_year":2009,"publication_date":"2009-03-16","ids":{"openalex":"https://openalex.org/W2160001758","doi":"https://doi.org/10.2337/dc08-2124","mag":"2160001758","pmid":"https://pubmed.ncbi.nlm.nih.gov/19289857","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2699702"},"language":"en","primary_location":{"id":"doi:10.2337/dc08-2124","doi":"https://doi.org/10.2337/dc08-2124","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc08-2124","pdf_url":"https://care.diabetesjournals.org/content/diacare/32/7/1224.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://care.diabetesjournals.org/content/diacare/32/7/1224.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090437675","display_name":"Bernard Zinman","orcid":"https://orcid.org/0000-0002-0041-1876","observed_orcids":["https://orcid.org/0000-0002-0041-1876"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]},{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Bernard Zinman","raw_affiliation_strings":["Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada;","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I210557978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114012252","display_name":"John E. Gerich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Gerich","raw_affiliation_strings":["Department of Medicine, University of Rochester, Rochester, New York;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Rochester, Rochester, New York;","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876","https://orcid.org/0000-0001-6894-4110"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John B. Buse","raw_affiliation_strings":["University of North Carolina, Chapel Hill, North Carolina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, North Carolina;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103371371","display_name":"Andrew J. Lewin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111119","display_name":"National Research Institute","ror":"https://ror.org/02201aj62","country_code":"US","type":"other","lineage":["https://openalex.org/I4210111119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Lewin","raw_affiliation_strings":["National Research Institute, Los Angeles, California;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Institute, Los Angeles, California;","institution_ids":["https://openalex.org/I4210111119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064307950","display_name":"Sherwyn Leon Schwartz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherwyn Schwartz","raw_affiliation_strings":["Diabetes and Glandular Disease Center, San Antonio, Texas;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Glandular Disease Center, San Antonio, Texas;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015275535","display_name":"Philip Raskin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Raskin","raw_affiliation_strings":["Department of Medicine, University of Texas, Dallas, Texas;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Texas, Dallas, Texas;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023487929","display_name":"Paula M. Hale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Paula M. Hale","raw_affiliation_strings":["Novo Nordisk, Copenhagen, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk, Copenhagen, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103492502","display_name":"Milan Zdravkovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Milan Zdravkovic","raw_affiliation_strings":["Novo Nordisk, Copenhagen, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk, Copenhagen, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070289715","display_name":"Lawrence Blonde","orcid":"https://orcid.org/0000-0003-0492-6698","observed_orcids":["https://orcid.org/0000-0003-0492-6698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Blonde","raw_affiliation_strings":["Ochsner Institute, New Orleans, Louisiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ochsner Institute, New Orleans, Louisiana","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"the LEAD-4 Study Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the LEAD-4 Study Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5090437675"],"corresponding_institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I210557978"],"apc_list":null,"apc_paid":null,"fwci":76.6628,"has_fulltext":true,"cited_by_count":842,"citation_normalized_percentile":{"value":0.99960629,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"32","issue":"7","first_page":"1224","last_page":"1230"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9200000166893005},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8159999847412109},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9919999837875366},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9660000205039978},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9100000262260437},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8209999799728394},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.9829999804496765},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.953000009059906},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6370000243186951},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.8069999814033508},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.9620000123977661},{"id":"https://openalex.org/keywords/proinsulin-insulin-ratio","display_name":"proinsulin/insulin ratio","score":0.8830000162124634},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.979736328125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.885718822479248},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8270852565765381},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.826646089553833},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6772647500038147},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6668500304222107},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.647868275642395},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.5849617719650269},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.5755220651626587},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5251585841178894},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.5084923505783081},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.4424193501472473},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3680833578109741},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2337/dc08-2124","doi":"https://doi.org/10.2337/dc08-2124","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc08-2124","pdf_url":"https://care.diabetesjournals.org/content/diacare/32/7/1224.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2699702","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2699702","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmid:19289857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19289857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:cdr.lib.unc.edu:sf268b76h","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/cn5s-c680","pdf_url":"https://cdr.lib.unc.edu/downloads/r494vs10t","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes Care, 32(7)","raw_type":"Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.358.5551","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.358.5551","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/86/69/Diabetes_Care_2009_Jul_16_32(7)_1224-1230.tar.gz","raw_type":"text"},{"id":"doi:10.17615/cn5s-c680","doi":"https://doi.org/10.17615/cn5s-c680","is_oa":true,"landing_page_url":"https://doi.org/10.17615/cn5s-c680","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.2337/dc08-2124","doi":"https://doi.org/10.2337/dc08-2124","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc08-2124","pdf_url":"https://care.diabetesjournals.org/content/diacare/32/7/1224.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2160001758.pdf","grobid_xml":"https://content.openalex.org/works/W2160001758.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1842832527","https://openalex.org/W1863279491","https://openalex.org/W1986331352","https://openalex.org/W2013851956","https://openalex.org/W2050826565","https://openalex.org/W2059555444","https://openalex.org/W2071835038","https://openalex.org/W2081276121","https://openalex.org/W2098459806","https://openalex.org/W2106036385","https://openalex.org/W2113094401","https://openalex.org/W2128077095","https://openalex.org/W2129730863","https://openalex.org/W2138290933","https://openalex.org/W2146649143","https://openalex.org/W2154828885","https://openalex.org/W2160234571","https://openalex.org/W2302447233","https://openalex.org/W2335557701","https://openalex.org/W2337454357","https://openalex.org/W2607031541","https://openalex.org/W2634243099","https://openalex.org/W2784536055","https://openalex.org/W4252564070"],"related_works":["https://openalex.org/W7098245968","https://openalex.org/W7095518845","https://openalex.org/W2138290933","https://openalex.org/W2137352234","https://openalex.org/W2071835038","https://openalex.org/W2509949587","https://openalex.org/W1998281835","https://openalex.org/W3031548469","https://openalex.org/W2061549173","https://openalex.org/W4248989620"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"the":[3,97,226],"efficacy":[4],"and":[5,18,56,85,111,115,128,133,136,139,147,166,173,199,204,208,215,222,259,267],"safety":[6],"of":[7,219],"liraglutide":[8,40,46,98,114,156,169,207,231],"(a":[9],"glucagon-like":[10],"peptide-1":[11],"receptor":[12],"agonist)":[13],"when":[14],"added":[15],"to":[16,38],"metformin":[17,51,266],"rosiglitazone":[19,57],"in":[20,48,96,213,225,282],"type":[21,64,276],"2":[22,65,277],"diabetes.":[23],"RESEARCH":[24],"DESIGN":[25],"AND":[26],"METHODS:":[27],"This":[28],"26-week,":[29],"double-blind,":[30],"placebo-controlled,":[31],"parallel-group":[32],"trial":[33],"randomized":[34],"533":[35],"subjects":[36],"(1:1:1)":[37],"once-daily":[39],"(1.2":[41],"or":[42,45,77],"1.8":[43,112,134,167,205],"mg)":[44],"placebo":[47,101,187],"combination":[49,81,273],"with":[50,164,183,186,202,230,239,253,265],"(1":[52],"g":[53],"twice":[54,60],"daily)":[55],"(4":[58],"mg":[59,113,135,168,206],"daily).":[61],"Subjects":[62],"had":[63],"diabetes,":[66,278],"A1C":[67,91],"7-11%":[68],"(previous":[69,79],"oral":[70],"antidiabetes":[71],"drug":[72],"[OAD]":[73],"monotherapy":[74],">or=3":[75,83],"months)":[76],"7-10%":[78],"OAD":[80],"therapy":[82,274],"months),":[84],"BMI":[86],"<or=45":[87],"kg/m(2).":[88],"RESULTS:":[89],"Mean":[90],"values":[92],"decreased":[93,124,143,195],"significantly":[94],"more":[95,237,251],"groups":[99,157],"versus":[100,232],"(mean":[102],"+/-":[103,106,117,171,175,189],"SE":[104],"-1.5":[105],"0.1%":[107,118],"for":[108,119,131,154,275],"both":[109],"1.2":[110,132,165,203],"-0.5":[116],"placebo).":[120,159],"Fasting":[121],"plasma":[122],"glucose":[123,142],"by":[125,144,196],"40,":[126],"44,":[127],"8":[129],"mg/dl":[130],"placebo,":[137,209],"respectively,":[138],"90-min":[140],"postprandial":[141],"47,":[145],"49,":[146],"14":[148],"mg/dl,":[149],"respectively":[150],"(P":[151,179],"<":[152,180],"0.001":[153],"all":[155],"vs.":[158],"Dose-dependent":[160],"weight":[161,184],"loss":[162],"occurred":[163,229,236,257],"(1.0":[170],"0.3":[172,176,190],"2.0":[174],"kg,":[177],"respectively)":[178],"0.0001)":[181],"compared":[182],"gain":[185],"(0.6":[188],"kg).":[191],"Systolic":[192],"blood":[193],"pressure":[194],"6.7,":[197],"5.6,":[198],"1.1":[200],"mmHg":[201],"respectively.":[210],"Significant":[211],"increases":[212],"C-peptide":[214],"homeostasis":[216],"model":[217],"assessment":[218],"beta-cell":[220],"function":[221],"significant":[223,280],"decreases":[224],"proinsulin-to-insulin":[227],"ratio":[228],"placebo.":[233],"Minor":[234],"hypoglycemia":[235],"frequently":[238],"liraglutide,":[240,254],"but":[241,255],"there":[242],"was":[243],"no":[244],"major":[245],"hypoglycemia.":[246],"Gastrointestinal":[247],"adverse":[248],"events":[249],"were":[250,260],"common":[252],"most":[256],"early":[258],"transient.":[261],"CONCLUSIONS:":[262],"Liraglutide":[263],"combined":[264],"a":[268,271],"thiazolidinedione":[269],"is":[270],"well-tolerated":[272],"providing":[279],"improvements":[281],"glycemic":[283],"control.":[284]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":27},{"year":2018,"cited_by_count":28},{"year":2017,"cited_by_count":42},{"year":2016,"cited_by_count":57},{"year":2015,"cited_by_count":61},{"year":2014,"cited_by_count":73},{"year":2013,"cited_by_count":57},{"year":2012,"cited_by_count":107}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}